S

Shanghai Kinetic Medical Co Ltd
SZSE:300326

Watchlist Manager
Shanghai Kinetic Medical Co Ltd
SZSE:300326
Watchlist
Price: 6.88 CNY 2.69% Market Closed
Market Cap: ¥4.9B

P/E

-54.6
Current
18%
More Expensive
vs 3-y average of -46.3

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
-54.6
=
Market Cap
¥4.6B
/
Net Income
¥-90.4m

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
-54.6
=
Market Cap
¥4.6B
/
Net Income
¥-90.4m

Valuation Scenarios

Shanghai Kinetic Medical Co Ltd is trading above its industry average

If P/E returns to its Industry Average (33.5), the stock would be worth ¥-4.23 (161% downside from current price).

Statistics
Positive Scenarios
0/2
Maximum Downside
-161%
Maximum Upside
No Upside Scenarios
Average Downside
158%
Scenario P/E Value Implied Price Upside/Downside
Current Multiple -54.6 ¥6.88
0%
Industry Average 33.5 ¥-4.23
-161%
Country Average 29.6 ¥-3.73
-154%

Forward P/E
Today’s price vs future net income

Today's Market Cap Net Income Forward P/E
¥4.6B
/
Oct 2025
¥-90.4m
=
-54.6
Current
¥4.6B
/
Dec 2025
¥144.8m
=
31.8
Forward
¥4.6B
/
Dec 2026
¥173.8m
=
26.5
Forward

Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.

Market Distribution

Lower than 100% of companies in China
Percentile
0th
Based on 5 557 companies
0th percentile
-54.6
Low
0 — 17.1
Typical Range
17.1 — 57.7
High
57.7 —
Distribution Statistics
China
Min 0
30th Percentile 17.1
Median 29.6
70th Percentile 57.7
Max 43 569.3

Shanghai Kinetic Medical Co Ltd
Glance View

Market Cap
4.9B CNY
Industry
Health Care

Shanghai Kinetic Medical Co., Ltd. engages in the research, development, manufacture and sale of medical devices dedicated to serve orthopedic minimally invasive surgerical needs. The company is headquartered in Shanghai, Shanghai and currently employs 1,107 full-time employees. The company went IPO on 2012-06-13. The firm is mainly engaged in the research, development, manufacture and sale of minimally invasive interventional surgical systems for vertebroplasty, the research, development, manufacture and sale of orthopedic medical devices, such as orthopedic implants and orthopedic surgical instruments, as well as the development, manufacture and sale of drug-eluting coronary stents. The firm operates its business in domestic market.

Intrinsic Value
4.54 CNY
Overvaluation 34%
Intrinsic Value
Price ¥6.88
S
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett